Haller et al. demonstrated that irinotecan plus oxaliplatin (IROX) is more efficacious than irinotecan alone after fluoropyrimidine failure in advanced colorectal cancer. IROX does not change ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback